Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9402326rdf:typepubmed:Citationlld:pubmed
pubmed-article:9402326lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:9402326lifeskim:mentionsumls-concept:C0243020lld:lifeskim
pubmed-article:9402326lifeskim:mentionsumls-concept:C0175659lld:lifeskim
pubmed-article:9402326lifeskim:mentionsumls-concept:C0349674lld:lifeskim
pubmed-article:9402326lifeskim:mentionsumls-concept:C0870840lld:lifeskim
pubmed-article:9402326lifeskim:mentionsumls-concept:C0071321lld:lifeskim
pubmed-article:9402326lifeskim:mentionsumls-concept:C0222045lld:lifeskim
pubmed-article:9402326pubmed:issue3-4lld:pubmed
pubmed-article:9402326pubmed:dateCreated1998-1-29lld:pubmed
pubmed-article:9402326pubmed:abstractTextWe have conjugated the murine monoclonal anti-CD7 antibody TXU to the plant hemitoxin pokeweed antiviral protein (PAP) to construct an effective immunotoxin against CD7 antigen positive hematologic malignancies. The scaled-up production and purification of TXU antibody, PAP toxin, and TXU-PAP immunotoxin permitted the manufacturing of a highly purified clinical-grade TXU-PAP preparation. In clonogenic assays, TXU-PAP elicited selective and potent cytotoxicity against CD7 antigen positive human leukemia cells and killed primary clonogenic leukemic cells from T-lineage acute lymphoblastic leukemia (ALL) patients. To our knowledge, this pre-IND work represents the first effort of producing a clinical-grade PAP immunotoxin for treatment of T-lineage ALL. Since the CD7 antigen is also expressed on AML cells, TXU-PAP could also be useful for the treatment of CD7 positive acute myeloid leukemia (AML) patients.lld:pubmed
pubmed-article:9402326pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:languageenglld:pubmed
pubmed-article:9402326pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:citationSubsetIMlld:pubmed
pubmed-article:9402326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9402326pubmed:statusMEDLINElld:pubmed
pubmed-article:9402326pubmed:monthOctlld:pubmed
pubmed-article:9402326pubmed:issn1042-8194lld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:HoffmanNNlld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:BellKKlld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:TurnerNNlld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:MyersD EDElld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:UckunF MFMlld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:DonelsonRRlld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:LanglieM CMClld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:JunXXlld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:ClementsonDDlld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:SarquisMMlld:pubmed
pubmed-article:9402326pubmed:authorpubmed-author:SichenederAAlld:pubmed
pubmed-article:9402326pubmed:issnTypePrintlld:pubmed
pubmed-article:9402326pubmed:volume27lld:pubmed
pubmed-article:9402326pubmed:ownerNLMlld:pubmed
pubmed-article:9402326pubmed:authorsCompleteYlld:pubmed
pubmed-article:9402326pubmed:pagination275-302lld:pubmed
pubmed-article:9402326pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:meshHeadingpubmed-meshheading:9402326-...lld:pubmed
pubmed-article:9402326pubmed:year1997lld:pubmed
pubmed-article:9402326pubmed:articleTitleLarge scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trials.lld:pubmed
pubmed-article:9402326pubmed:affiliationHughes Institute, St. Paul, Minnesota 55113, USA.lld:pubmed
pubmed-article:9402326pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9402326pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9402326pubmed:publicationTypeReviewlld:pubmed
pubmed-article:9402326pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9402326lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9402326lld:pubmed